HEXAXIM

Suspension for injection in pre-filled syringe, 20i.j./0.5ml + 12mcg/0.5ml + 22-36mcgT/0.5ml + 25mcg/0.5ml + 25mcg/0.5ml + 29D antigen jedinica/0.5ml + 7D antigen jedinica/0.5ml + 26D antigen jedinica/0.5ml + 40i.j./0.5ml + 10mcg/0.5ml

RxActive license

Active substance (INN)

diphtheria, Haemophilus influenzae type b (conjugate, adsorbed), pertussis (acellular), poliomyelitis (inactivated), tetanus and hepatitis B (recombinant) vaccine, combined

Pharmaceutical form

Pharmaceutical formSuspension for injection in pre-filled syringe

Strength20i.j./0.5ml + 12mcg/0.5ml + 22-36mcgT/0.5ml + 25mcg/0.5ml + 25mcg/0.5ml + 29D antigen jedinica/0.5ml + 7D antigen jedinica/0.5ml + 26D antigen jedinica/0.5ml + 40i.j./0.5ml + 10mcg/0.5ml

PackagingUkupno 1 napunjeni injekcioni špric sa 0.5ml suspenzije za injekciju (sa 2 igle) u kartonskoj kutiji

ManufacturerSanofi Winthrop Industrie, France

Therapeutic groupAnti-infectives for systemic use (J07CA09)

Marketing authorization holderAMICUS PHARMA DOO PODGORICA

Authorization dateFebruary 13, 2026

Source: CInMED register